Rhythm Pharmaceuticals, Inc. RYTM Strategic investments
Strategic investments at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLongTermInvestments.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s strategic investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s strategic investments?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported strategic investments of $2.52M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s strategic investments changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s strategic investments decreased by 64.8% year-over-year, from $7.14M to $2.52M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s strategic investments?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s strategic investments has grown at a -27.4% compound annual growth rate (CAGR), from $11.82M to $3.29M.